About the 2015 Summit Partners:
British Columbia’s healthcare infrastructure has benefited from investments in medical research and the outcomes are supporting the development of new medical technologies that use information from genome science to provide more accurate diagnoses and to ensure that patients receive the right treatment at the right time, which is the foundation for personalized medicine. Genome BC’s funded programs and projects have played an important role in medical research and Genome BC is now poised to contribute to the translation of this new knowledge into clinical practice.
Genome BC is supported by the Province of British Columbia, the Government of Canada through Genome Canada and Western Economic Diversification Canada and more than 300 international public and private co-funding partners.
All life sciences sectors, from biopharmaceuticals and medical devices, to bioproducts and bioenergy, forest, agricultural and marine biotech, are integrated into our organization and all that we do, ensuring that no life sciences sector is working in isolation — and that all sectors come together in a comprehensive, complementary and coordinated fashion.
Throughout the year, LifeSciences BC undertakes numerous programs and projects in support of these sectors. These include public policy initiatives, facilitating linkages between global industry and our local organizations, raising the profile of our industry internationally and thus facilitating investment and global partnering opportunities, and helping nurture economic development in British Columbia through the life sciences industry.
The Centre of Excellence for Prevention of Organ Failure (PROOF Centre) develops high-value blood tests to predict, diagnose, prognose, and better treat and manage vital organ failure, with a particular emphasis on heart, lung and kidney diseases. The PROOF Centre is a cross-disciplinary engine of computational and life scientists, clinicians, economists, commercialization leaders, technology experts, and health system advisors committed to harnessing the information that resides in molecular features like mRNA, microRNA, proteins, metabolites and epigenetic marks through an advanced computational pipeline of analytics and systems science, ultimately rendering uniquely useful clinical laboratory tests and discriminative signatures to support more effective drug development.
PROOF Centre embraces local, national and international partners from academia, health care, government, industry and the public, all concerned with improving health and reducing the enormous socioeconomic burden of organ failure. As an independent not-for-profit society established in 2008 by competitive funding from the Networks of Centres of Excellence Secretariat under the Centre of Excellence for Commercialization and Research (NCE CECR) Program, and funded by many public and private sector organizations, the PROOF Centre is co-hosted by the University of British Columbia and Providence Health Care in Vancouver, British Columbia, Canada. For more information visit www.proofcentre.ca or contact leaders at firstname.lastname@example.org
The Centre for Drug Research and Development – www.cdrd.ca
The Centre for Drug Research and Development (CDRD) addresses one of the biggest challenges facing the life sciences sector today: how to translate commercially promising health research conducted at the university level into new therapies that improve and save lives
CDRD is Canada’s national, not-for-profit drug development and commercialization centre. Their mandate is to de-risk discoveries stemming from publicly funded research to create viable investment opportunities for the private sector— thereby bridging the commercialization gap between early-stage academic research and industry. CDRD is the only fully-integrated centre of its kind in the country — and one of a handful in the world — with the full expertise and infrastructure to source, evaluate, develop and commercialize both small molecule and biologic innovative technologies in virtually any therapeutic area.